Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients

• Status: Not yet recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized, controlled multicenter clinical trial. The purpose of this study is to compare the continuous infusion of vancomycin with intermittent infusion regarding the effectiveness to reach the target serum level and the relationship between infusion type and nephrotoxicity in critically ill patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Sao Paulo
• Treatments: Vancomycin

Criteria

Inclusion Criteria:

• Critically ill patients

• Treatment with vancomycin

• Preserved renal function.

Exclusion Criteria:

• Cystic fibrosis

• Chronic renal failure

• Acute renal failure

• Having received vancomycin in the last 24 hours

• Vancomycin hypersensibility